Literature DB >> 22870496

Aging and bone loss: new insights for the clinician.

Oddom Demontiero, Christopher Vidal, Gustavo Duque.   

Abstract

It is well known that the underlying mechanisms of osteoporosis in older adults are different than those associated with estrogen deprivation. Age-related bone loss involves a gradual and progressive decline, which is also seen in men. Markedly increased bone resorption leads to the initial fall in bone mineral density. With increasing age, there is also a significant reduction in bone formation. This is mostly due to a shift from osteoblastogenesis to predominant adipogenesis in the bone marrow, which also has a lipotoxic effect that affects matrix formation and mineralization. We review new evidence on the pathophysiology of age-related bone loss with emphasis upon the mechanism of action of current osteoporosis treatments. New potential treatments are also considered, including therapeutic approaches to osteoporosis in the elderly that focus on the pathophysiology and potential reversal of adipogenic shift in bone.

Entities:  

Keywords:  aging; elderly; osteoblast; osteoclast; osteoporosis; treatment

Year:  2012        PMID: 22870496      PMCID: PMC3383520          DOI: 10.1177/1759720X11430858

Source DB:  PubMed          Journal:  Ther Adv Musculoskelet Dis        ISSN: 1759-720X            Impact factor:   5.346


  145 in total

1.  Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

Authors:  J Y Reginster; E Seeman; M C De Vernejoul; S Adami; J Compston; C Phenekos; J P Devogelaer; M Diaz Curiel; A Sawicki; S Goemaere; O H Sorensen; D Felsenberg; P J Meunier
Journal:  J Clin Endocrinol Metab       Date:  2005-02-22       Impact factor: 5.958

2.  Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women.

Authors:  C Slemenda; C Longcope; M Peacock; S Hui; C C Johnston
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

3.  Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial.

Authors:  J D Adachi; K G Saag; P D Delmas; U A Liberman; R D Emkey; E Seeman; N E Lane; J M Kaufman; P E Poubelle; F Hawkins; R Correa-Rotter; C J Menkes; J A Rodriguez-Portales; T J Schnitzer; J A Block; J Wing; H H McIlwain; R Westhovens; J Brown; J A Melo-Gomes; B L Gruber; M J Yanover; M O Leite; K G Siminoski; M C Nevitt; J T Sharp; M P Malice; T Dumortier; M Czachur; W Carofano; A Daifotis
Journal:  Arthritis Rheum       Date:  2001-01

4.  Osteopenia in the immobilized rat hind limb is associated with increased bone resorption and decreased bone formation.

Authors:  M Weinreb; G A Rodan; D D Thompson
Journal:  Bone       Date:  1989       Impact factor: 4.398

5.  Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial.

Authors:  Susan L Greenspan; Henry G Bone; Mark P Ettinger; David A Hanley; Robert Lindsay; Jose R Zanchetta; Consuelo M Blosch; Annette L Mathisen; Stephen A Morris; Thomas B Marriott
Journal:  Ann Intern Med       Date:  2007-03-06       Impact factor: 25.391

6.  Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men.

Authors:  A Falahati-Nini; B L Riggs; E J Atkinson; W M O'Fallon; R Eastell; S Khosla
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

7.  Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy.

Authors:  J-M Kaufman; E Orwoll; S Goemaere; J San Martin; A Hossain; G P Dalsky; R Lindsay; B H Mitlak
Journal:  Osteoporos Int       Date:  2004-08-18       Impact factor: 4.507

Review 8.  Update in male osteoporosis.

Authors:  Sundeep Khosla
Journal:  J Clin Endocrinol Metab       Date:  2010-01       Impact factor: 5.958

Review 9.  Glucocorticoid-induced osteoporosis: pathophysiology and therapy.

Authors:  E Canalis; G Mazziotti; A Giustina; J P Bilezikian
Journal:  Osteoporos Int       Date:  2007-06-14       Impact factor: 4.507

10.  A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure.

Authors:  Vijay K Yadav; Franck Oury; Nina Suda; Zhong-Wu Liu; Xiao-Bing Gao; Cyrille Confavreux; Kristen C Klemenhagen; Kenji F Tanaka; Jay A Gingrich; X Edward Guo; Laurence H Tecott; J John Mann; Rene Hen; Tamas L Horvath; Gerard Karsenty
Journal:  Cell       Date:  2009-09-04       Impact factor: 41.582

View more
  121 in total

Review 1.  Exercise: the lifelong supplement for healthy ageing and slowing down the onset of frailty.

Authors:  Jose Viña; Leocadio Rodriguez-Mañas; Andrea Salvador-Pascual; Francisco José Tarazona-Santabalbina; Mari Carmen Gomez-Cabrera
Journal:  J Physiol       Date:  2016-04-15       Impact factor: 5.182

2.  The exploration of feature extraction and machine learning for predicting bone density from simple spine X-ray images in a Korean population.

Authors:  Sangwoo Lee; Eun Kyung Choe; Hae Yeon Kang; Ji Won Yoon; Hua Sun Kim
Journal:  Skeletal Radiol       Date:  2019-11-23       Impact factor: 2.199

3.  Inactivation of Vhl in osteochondral progenitor cells causes high bone mass phenotype and protects against age-related bone loss in adult mice.

Authors:  Tujun Weng; Yangli Xie; Junlan Huang; Fengtao Luo; Lingxian Yi; Qifen He; Di Chen; Lin Chen
Journal:  J Bone Miner Res       Date:  2014-04       Impact factor: 6.741

4.  Association of use of rehabilitation services with development of osteoporosis among patients with rheumatoid arthritis: a nationwide population-based cohort study.

Authors:  L-C Liu; M-C Lu; S-Y Wang; H Livneh; N-S Lai; T-Y Tsai
Journal:  Osteoporos Int       Date:  2018-06-27       Impact factor: 4.507

Review 5.  Targeting Cell Senescence for the Treatment of Age-Related Bone Loss.

Authors:  Robert J Pignolo; Rebekah M Samsonraj; Susan F Law; Haitao Wang; Abhishek Chandra
Journal:  Curr Osteoporos Rep       Date:  2019-04       Impact factor: 5.096

6.  Identification of Hip BMD Loss and Fracture Risk Markers Through Population-Based Serum Proteomics.

Authors:  Carrie M Nielson; Jack Wiedrick; Jian Shen; Jon Jacobs; Erin S Baker; Aaron Baraff; Paul Piehowski; Christine G Lee; Arie Baratt; Vladislav Petyuk; Shannon McWeeney; Jeong Youn Lim; Douglas C Bauer; Nancy E Lane; Peggy M Cawthon; Richard D Smith; Jodi Lapidus; Eric S Orwoll
Journal:  J Bone Miner Res       Date:  2017-04-06       Impact factor: 6.741

Review 7.  MicroRNAs as modulators of longevity and the aging process.

Authors:  Holly E Kinser; Zachary Pincus
Journal:  Hum Genet       Date:  2019-07-11       Impact factor: 4.132

8.  Pyk2 deficiency potentiates osteoblast differentiation and mineralizing activity in response to estrogen or raloxifene.

Authors:  Sumana Posritong; Jung Min Hong; Pierre P Eleniste; Patrick W McIntyre; Jennifer L Wu; Evan R Himes; Vruti Patel; Melissa A Kacena; Angela Bruzzaniti
Journal:  Mol Cell Endocrinol       Date:  2018-02-08       Impact factor: 4.102

9.  Post-antibiotic gut dysbiosis-induced trabecular bone loss is dependent on lymphocytes.

Authors:  Naiomy Deliz Rios-Arce; Jonathan D Schepper; Andrew Dagenais; Laura Schaefer; Connor S Daly-Seiler; Joseph D Gardinier; Robert A Britton; Laura R McCabe; Narayanan Parameswaran
Journal:  Bone       Date:  2020-02-21       Impact factor: 4.398

10.  Deletion of PPARγ in Mesenchymal Lineage Cells Protects Against Aging-Induced Cortical Bone Loss in Mice.

Authors:  Jay Cao; Kehong Ding; Guodong Pan; Raysa Rosario; Yun Su; Yonggang Bao; Hongyan Zhou; Jianru Xu; Meghan E McGee Lawrence; Mark W Hamrick; Carlos M Isales; Xingming Shi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-04-17       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.